SYSTEMATIC REVIEW
Accepted on 17 Dec 2025
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Understanding and Controlling Adverse Effects in Myeloma Patients treated with T Cell Redirecting Immunotherapies
Understanding and Controlling Adverse Effects in Myeloma Patients treated with T Cell Redirecting Immunotherapies
632
Total downloads
5,630
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 16 Oct 2025
Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h
doi 10.3389/fimmu.2025.1654096
- 1,468 views
ORIGINAL RESEARCH
Published on 13 Aug 2025
The silent signals: emerging safety concerns in bispecific antibody therapy for multiple myeloma
doi 10.3389/fmed.2025.1593405
- 2,779 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: